Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
Collection of CIVARS data for the medicine Prevymis in the context of an MEA Last updated: 2023-02-03 03:36